The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 276K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsujimura, K.
Right arrow Articles by Obata, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsujimura, K.
Right arrow Articles by Obata, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1996/12/2175/ $5.00
The Journal of Experimental Medicine, Volume 184, Number 6, December 1, 1996 2175-2184


Articles

Positive Selection of {gamma}{delta} CTL by TL Antigen Expressed in the Thymus

Kunio Tsujimura*, Toshitada Takahashi*, Akimichi Morita*,{ddagger}, Hitomi Hasegawa-Nishiwaki*, Shigeru Iwase*,§, and Yuichi Obata*

From the * Laboratory of Immunology, Aichi Cancer Center Research Institute, Chikusa-ku, Nagoya 464, Japan; {ddagger} Department of Dermatology, Nagoya City University School of Medicine, Mizuho-ku, Nagoya 467, Japan; and § Department of Chemical Hygiene and Nutrition, Faculty of Pharmaceutical Sciences, Nagoya City University, Mizuho-ku, Nagoya 467, Japan

To elucidate the function of the mouse TL antigen in the thymus, we have derived two TL transgenic mouse strains by introducing Tlaa-3 of A strain origin with its own promoter onto a C3H background with no expression of TL in the thymus. These transgenic mouse strains, both of which express high levels of Tlaa-3-TL antigen in their thymus, were analyzed for their T cell function with emphasis on cytotoxic T lymphocyte (CTL) generation. A T cell response against TL was induced in Tg.Tlaa-3-1, Tg.Tlaa-3-2, and control C3H mice by skin grafts from H-2Kb/T3b transgenic mice, Tg.Con.3-1, expressing T3b-TL ubiquitously. Spleen cells from mice that had rejected the T3b-TL positive skin grafts were restimulated in vitro with Tg.Con.3-1 irradiated spleen cells. In mixed lymphocyte cultures (MLC), approximately 20% and 15% of Thy-1+ T cells derived from Tg.Tlaa-3-1 and Tg.Tlaa-3-2, respectively, expressed TCR{gamma}{delta}, whereas almost all those from C3H expressed TCR{alpha}β. The MLC from Tg.Tlaa-3-2 and C3H demonstrated high CTL activity against TL, while those from Tg.Tlaa-3-1 had little or none. The generation of {gamma}{delta} CTL recognizing TL in Tg.Tlaa-3-2, but not C3H mice, was confirmed by the establishment of CTL clones. A total of 14 {gamma}{delta} CTL clones were established from Tg.Tlaa-3-2, whereas none were obtained from C3H. Of the 14 {gamma}{delta} CTL clones, 8 were CD8+ and 6 were CD4CD8 double negative. The CTL activity of all these clones was TL specific and inhibited by anti-TL, but not by anti-H-2 antibodies, demonstrating that they recognize TL directly without antigen presentation by H-2. The CTL activity was blocked by antibodies to TCR{gamma}{delta} and CD3, and also by antibodies to CD8{alpha} and CD8β in CD8+ clones, showing that the activity was mediated by TCR{gamma}{delta} and coreceptors. The thymic origin of these {gamma}{delta} CTL clones was indicated by the expression of Thy-1 and Ly-1 (CD5), and also CD8{alpha}β heterodimers in CD8+ clones on their surfaces and by the usage of TCR V{gamma}4 chains in 12 of the 14 clones. Taken together, these results suggest that Tlaa-3-TL antigen expressed in the thymus engages in positive selection of a sizable population of {gamma}{delta} T cells.


Address correspondence to Yuichi Obata, Laboratory of Immunology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya 464, Japan.

We are indebted to Dr. L.J. Old for his continuous encouragement and advice thoughout these studies. We thank Y. Matsudaira, S. Ozeki, and H. Tamaki for their excellent technical assistance. We thank Dr. K. Furukawa, Dr. K. Kuribayashi, Dr. M. Miyasaka, Dr. M. Muto, Dr. E. Nakayama, Dr. S. Sakaguchi, and Dr. H. Yagita for their kind gifts of monoclonal antibodies.

1Abbreviations used in this paper: B6, C57BL/6; C3H, C3H/He; cAb, conventional antibody; DN, CD4CD8 double negative; Ltk, thymidine kinase-negative L cell; MFI, mean fluorescence intensity; PBR, peptide binding region; RT, reverse transcription.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS